| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.1 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |